E3 ligase HERC5-catalyzed UGDH isgylation promotes SNAI1-mediated tumor metastasis and cisplatin resistance in oral squamous cell carcinoma

E3 ligase HERC5-catalyzed UGDH isgylation promotes SNAI1-mediated tumor metastasis and cisplatin resistance in oral squamous cell carcinoma

Abstract Background Oral squamous cell carcinoma (OSCC) is one of the leading causes of cancer-related mortality worldwide due to its high aggressive potential and drug resistance. Previous studies have revealed an important function of HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 5 (H...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xu Zhang, Fayu Liu, Qigen Fang, Changfu Sun, Jie Fan
Format:	Article
Language:	English
Published:	BMC 2025-03-01
Series:	Biology Direct
Subjects:	HERC5 Oral squamous cell carcinoma Metastasis Cisplatin sensitivity ISGylation UGDH
Online Access:	https://doi.org/10.1186/s13062-025-00622-1
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ISGylation and E3 ubiquitin ligases: an Atlantic salmon genetic perspective
by: Unni Grimholt, et al.
Published: (2025-06-01)

Spermidine reduces ISGylation and enhances ISG15–USP18 interaction
by: Haruka Etori, et al.
Published: (2025-05-01)

Hepatocyte‐Targeted Lipid Nanoparticle Delivery of HERC2 Plasmid Controls Drug‐Induced Hepatotoxicity by Limiting β‐Catenin‐Regulated CYP2E1 Expression
by: Yunzhi Liu, et al.
Published: (2024-12-01)

Porcine reproductive and respiratory syndrome virus NSP5 exploited UBE2L6 to promote viral replication via antagonising host RLRs and ISGylation
by: Zhenbang Zhu, et al.
Published: (2025-07-01)

Chasing Virus Replication and Infection: PAMP-PRR Interaction Drives Type I Interferon Production, Which in Turn Activates ISG Expression and ISGylation
by: Imaan Muhammad, et al.
Published: (2025-04-01)

Hexokinase 2 promotes ISGylation of Acyl-CoA synthetase long-chain family member 4 in sepsis-induced microglia cells
by: Guangyang Bai, et al.
Published: (2025-04-01)

Anthropology of the Finno-Ugric Peoples: The Question of Pigmentation in the Aspect of Application
by: Murat A. Dzhaubermezov1, et al.
Published: (2024-12-01)

The emerging roles of ubiquitin-like modifications in regulating HIV replication and host defense
by: Jinsong Yuan, et al.
Published: (2025-06-01)

The Association of OLFM4 with the Progression and Cisplatin Resistance of Head and Neck Squamous Carcinoma
by: Xinlu He, et al.
Published: (2025-05-01)

Cisplatin and the Dissolution of Electrodes in Electrochemistry Experiments
by: Ross Milton, et al.
Published: (2025-02-01)

Nanotherapeutic interventions to enhance cisplatin sensitivity in ovarian cancer cells
by: Disha Mittal, et al.
Published: (2025-08-01)

Amelioration of cisplatin-induced hepatotoxicity by statins in rats
by: R A Maheshwari, et al.
Published: (2015-01-01)

PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma
by: Peipei Zhang, et al.
Published: (2024-11-01)

Cisplatin, the Timeless Molecule
by: Annaluisa Mariconda, et al.
Published: (2025-07-01)

Cisplatin induced paroxysmal supraventricular tachycardia
by: Waseem Raja, et al.
Published: (2013-01-01)

PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma
by: Zeyu Wang, et al.
Published: (2025-03-01)

Analytical study on the efficacy of neoadjuvant chemotherapy using a combination of methotrexate, bleomycin, and cisplatin in the management of advanced squamous cell carcinoma of the buccal mucosa
by: Santosh Manohar Kumar, et al.
Published: (2017-01-01)

The Protective Effect of Resveratrol on Cisplatin Induced Damage in Rat Liver
by: Ozlem Kara, et al.
Published: (2022-09-01)

Cisplatin‐coordinated copolythiophene for synergistic chemotherapy and sonodynamic therapy of tumor
by: Yuanyu Tang, et al.
Published: (2024-09-01)

Internal computational dosimetry of natural cisplatin activated in neutron flux
by: Giovana Bussolotti, et al.
Published: (2022-07-01)

Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma
by: Xuewen Yang, et al.
Published: (2024-12-01)

Astragaloside-IV Inhibits Metastasis by Suppressing the SDF-1/CXCR4 Axis and Activating Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells
by: Burçin İrem Abas, et al.
Published: (2024-05-01)

Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats
by: Ozlem Kara, et al.
Published: (2024-01-01)

Quantification of Cisplatin Encapsulated in Nanomedicine: An Overview
by: Ziwen Zhang, et al.
Published: (2025-05-01)

Mass spectrometry-based proteomic analysis to characterize cisplatin induced early signaling events in head and neck squamous cell carcinoma
by: Ankit P. Jain, et al.
Published: (2024-12-01)

Efficacy of neoadjuvant chemotherapy with docetaxel and cisplatin in patients with squamous cell carcinoma of the oral cavity at high risk of progression
by: S. I. Kutukova, et al.
Published: (2025-07-01)

Mitophagy Protects Against Cisplatin-Induced Injury in Granulosa Cells
by: Sihui Zhu, et al.
Published: (2025-04-01)

Knockdown of Keratin 6 Within Arsenite-Transformed Human Urothelial Cells Decreases Basal/Squamous Expression, Inhibits Growth, and Increases Cisplatin Sensitivity
by: Nelofar Nargis, et al.
Published: (2024-10-01)

Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy—A State-of-the-Art Review
by: Olaf Rose, et al.
Published: (2024-12-01)

Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
by: Tatpong Sriyapai, et al.
Published: (2022-06-01)

Additional radiation effect on cell viability using neutron irradiated Cisplatin and Carboplatin: preliminary results
by: Alexandre Soares Leal, et al.
Published: (2025-02-01)

MTMR6 downregulation contributes to cisplatin resistance in oral squamous cell carcinoma
by: Kah Young Lee, et al.
Published: (2025-01-01)

POLYSACCHARIDES TUSSILAGOFARFARA L. REDUCE MYELOSUPPRESSION INDUCED BY CISPLATIN AND ETOPOSIDE
by: E. A. Safonova, et al.
Published: (2017-09-01)

Effectiveness of hesperidin and rutin on cisplatin-induced testicular dysfunction in rats
by: Dina M. I. Heibashy, et al.
Published: (2025-07-01)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
by: Devleena, et al.
Published: (2010-03-01)

Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell
by: Jonathan González García, et al.
Published: (2017-01-01)

EFFECT OF CISPLATIN ON HEMOSTASIS IN EXPERIMENTAL ANIMALS
by: M. V. Filonova, et al.
Published: (2020-07-01)

Antitumor Effects of Hesperidin and Cisplatin on Human Osteosarcoma Cells Through Inhibiting Proliferation and Inducing Mitochondrial-Mediated Apoptosis
by: Mehmet Onur Ziyadanoğulları, et al.
Published: (2025-05-01)